Perrigo Company closes $4 bln buy of Omega Pharma
Perrigo Company plc said Monday it completed its buy of Omega Pharma Invest N.V. in a deal valued at 3.8 billion Euros (US$4 billion), which includes 1.3 billion in debt. Sellers are Marc Coucke, Waterland Private Equity Fund V CV and the co-investors of Waterland. The deal was announced in November. Omega, of Belgium, sells prescription-free medicines, healthcare products and personal care items such as wart treatments and suntan lotions over the counter, Reuters News said.
31 March 2015•5 mins read
